CL2010000166A1 - Uso de gaboxadol para preparar una composicion farmaceutica para ser utilizada en combinacion con un inhibidor de la reabsorcion de serotonina o con cualquier otro compuesto que logre una elevacion en el nivel de serotonina extracelular; y composicion farmaceutica (sol. div. 1607-04). - Google Patents
Uso de gaboxadol para preparar una composicion farmaceutica para ser utilizada en combinacion con un inhibidor de la reabsorcion de serotonina o con cualquier otro compuesto que logre una elevacion en el nivel de serotonina extracelular; y composicion farmaceutica (sol. div. 1607-04).Info
- Publication number
- CL2010000166A1 CL2010000166A1 CL2010000166A CL2010000166A CL2010000166A1 CL 2010000166 A1 CL2010000166 A1 CL 2010000166A1 CL 2010000166 A CL2010000166 A CL 2010000166A CL 2010000166 A CL2010000166 A CL 2010000166A CL 2010000166 A1 CL2010000166 A1 CL 2010000166A1
- Authority
- CL
- Chile
- Prior art keywords
- pharmaceutical composition
- serotonin
- gaboxadol
- div
- sol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Uso de gaboxadol para preparar una composición farmacéutica para ser utilizada en combinación con un inhibidor de la reabsorción de serotonina o con cualquier otro compuesto que logre una elevación en el nivel de serotonina extracelular; y composición farmacéutica (Sol. Div. 1607-04).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200300956 | 2003-06-25 | ||
DKPA200400016 | 2004-01-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2010000166A1 true CL2010000166A1 (es) | 2010-07-02 |
Family
ID=58707228
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200401607A CL2004001607A1 (es) | 2003-06-25 | 2004-06-24 | Uso de gabaxafol para preparar un medicamento util en el tratamiento de la depresion. |
CL2010000166A CL2010000166A1 (es) | 2003-06-25 | 2010-02-25 | Uso de gaboxadol para preparar una composicion farmaceutica para ser utilizada en combinacion con un inhibidor de la reabsorcion de serotonina o con cualquier otro compuesto que logre una elevacion en el nivel de serotonina extracelular; y composicion farmaceutica (sol. div. 1607-04). |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200401607A CL2004001607A1 (es) | 2003-06-25 | 2004-06-24 | Uso de gabaxafol para preparar un medicamento util en el tratamiento de la depresion. |
Country Status (10)
Country | Link |
---|---|
KR (1) | KR20060025192A (es) |
AR (1) | AR047550A1 (es) |
CA (2) | CA2692334A1 (es) |
CL (2) | CL2004001607A1 (es) |
EA (1) | EA200600101A1 (es) |
IS (1) | IS8138A (es) |
ME (2) | MEP1908A (es) |
NO (1) | NO20060229L (es) |
RS (1) | RS20050911A (es) |
TW (1) | TW200509918A (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113395962A (zh) | 2018-11-21 | 2021-09-14 | Certego治疗公司 | 加波沙朵用于降低自杀风险和快速缓解抑郁症 |
CA3182508A1 (en) | 2020-05-20 | 2021-11-25 | Certego Therapeutics Inc. | Ring deuterated gaboxadol and its use for the treatment of psychiatric disorders |
-
2004
- 2004-06-15 TW TW093117156A patent/TW200509918A/zh unknown
- 2004-06-23 AR ARP040102200A patent/AR047550A1/es not_active Application Discontinuation
- 2004-06-24 CL CL200401607A patent/CL2004001607A1/es unknown
- 2004-06-25 CA CA2692334A patent/CA2692334A1/en not_active Abandoned
- 2004-06-25 ME MEP-19/08A patent/MEP1908A/xx unknown
- 2004-06-25 CA CA002529805A patent/CA2529805A1/en not_active Abandoned
- 2004-06-25 KR KR1020057024823A patent/KR20060025192A/ko not_active Application Discontinuation
- 2004-06-25 ME MEP-2008-19A patent/ME00030B/me unknown
- 2004-06-25 EA EA200600101A patent/EA200600101A1/ru unknown
- 2004-06-25 RS YUP-2005/0911A patent/RS20050911A/sr unknown
-
2005
- 2005-11-21 IS IS8138A patent/IS8138A/is unknown
-
2006
- 2006-01-16 NO NO20060229A patent/NO20060229L/no not_active Application Discontinuation
-
2010
- 2010-02-25 CL CL2010000166A patent/CL2010000166A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
ME00030B (me) | 2010-06-10 |
KR20060025192A (ko) | 2006-03-20 |
NO20060229L (no) | 2006-01-16 |
CA2692334A1 (en) | 2004-12-29 |
EA200600101A1 (ru) | 2006-06-30 |
RS20050911A (en) | 2007-08-03 |
CL2004001607A1 (es) | 2005-05-27 |
TW200509918A (en) | 2005-03-16 |
MEP1908A (xx) | 2010-02-10 |
IS8138A (is) | 2005-11-21 |
AR047550A1 (es) | 2006-01-25 |
CA2529805A1 (en) | 2004-12-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR048878A1 (es) | Composiciones topicas de metadona y metodos para usarlas | |
ES2487496T3 (es) | Agente para aliviar el síndrome metabólico | |
CL2008001656A1 (es) | Anticuerpo anti-c3b; composicion farmaceutica que lo comprende, y su uso para prevenir o tratar un trastorno asociado con el complemento; kit que lo contiene. | |
ES2629749T3 (es) | Inmunidad tumoral | |
CL2007001391A1 (es) | Compuestos derivados de pirrolidinas sustituidas, inhibidores del factor xa y/o inhibidores sobre la serina proteasa; composicion farmaceutica que comprende a dichos compuestos; proedimiento para preparar la composicon farmaceutica; y uso de los compuestos preparar un medicamneto con un efecto antitrombotico | |
ES2422556T3 (es) | Tratamiento de hepatitis vírica | |
CR10307A (es) | Anteojos con caracteristicas de union a una mascarilla | |
AR047651A1 (es) | Composicion alimenticia con fibras | |
RS50510B (sr) | Formulacije koje sadrže ekteinascidin i disaharid | |
AR058753A1 (es) | Uso de composiciones nutricionales con fosfolipidos esfingolipidos y colesterol | |
ECSP109852A (es) | Uso de homo y copolímeros para la estabilización de formulaciones de principios activos | |
AR032803A1 (es) | Una composicion de aceite base, su procedimiento de preparacion, formulacion lubricante que comprende el aceite base y su uso. | |
NO20072839L (no) | 4-hydroksybenzomorfaner | |
ECSP088461A (es) | Composiciones farmacéuticas que contienen buprenorfina | |
ES2570856T3 (es) | Composiciones oftálmicas que contienen una combinación sinérgica de dos polímeros | |
ECSP099086A (es) | Comprimido masticable que contiene fenilefrina | |
PA8513601A1 (es) | Composiciones farmaceuticas de inhibidores de la glucogenofosforilasa | |
AR059330A1 (es) | Composiciones acondicionadoras del cabello | |
CL2008001072A1 (es) | Bloque de limpieza de inodoro que es al menos parcialmente transparente o translucida, que comprende 2 - 50% de material biocida y 50 - 98% de composicion portadora que comprende 5 - 50% de agente jabon, 30 - 90% de humectante, 5 - 30% de solvente; metodo para proporcionar higiene en un inodoro; y uso del bloque | |
AR070850A1 (es) | Dispositivo para mejorar un metodo de voladura | |
PA8577201A1 (es) | 3-fenil-propionamido, 3-fenil-acrilamido y derivados 3-fenil-propinamido como inhibidores de mao-b | |
AR047553A1 (es) | La combinacion de un inhibidor de reabsorcion de serotonina y agomelatina | |
UY27203A1 (es) | Bencimidazoles útiles en el tratamiento de la disfunción sexual | |
CO6551744A2 (es) | Combinación de fármacos con teobromina y su uso en terapia | |
UY27610A1 (es) | Combinación de inhibidores de ptm o inhibidores de la secreción de apob con fibratos para la utilización como medicamentos |